Screen · Berkshire Criteria

Buffett Quality Screen

Buffett's "wonderful business" criteria, quantified into six dimensions: earnings record (20), ROE quality (25 — Fortune's double standard), low leverage (15), pricing power (15), business stability (15) and capital efficiency (10), for a 0–100 total. The entry gate is the first of Berkshire's acquisition criteria — at least $50M average pre-tax earnings over the last three fiscal years (banks and insurers excluded, as leverage is their business model; investment trusts and closed-end funds excluded, as they are portfolios rather than operating companies). Recomputed periodically from each company's last ten fiscal years; cross-listings merged by canonical ticker. Hover the score for the six-dimension breakdown; companies we cover link to their report. Filtré par score tier "Élite", market cap "Mid $2–10B", profit streak "≥5 yr" : 88 match(effacer les filtres).

#	Titre	Mkt Cap	Score▼	10Y ROE	Profit Streak	Net Debt/Eq	Gross Margin	Étude	FY
1	AJ Bell plc AJB · LSE	$2.9B	97/100 Élite	35.9%low 24.8%	10 yr+	Net cash	100%	—	FY2025
2	Federated Investors Inc B FHI · États-Unis	$4.6B	96/100 Élite	28.6%low 22.9%	10 yr+	Net cash	68%	—	FY2025
3	Paycom Software, Inc. PAYC · États-Unis	$7.6B	95/100 Élite	28.8%low 21.9%	10 yr+	Net cash	84%	—	FY2025
4	WD-40 Company WDFC · États-Unis	$3.0B	95/100 Élite	36.0%low 30.2%	10 yr+	0.1×	54%	—	FY2025
5	National Beverage Corp FIZZ · États-Unis	$3.0B	95/100 Élite	41.0%low 28.7%	10 yr+	Net cash	37%	—	FY2026
6	Games Workshop Group PLC GAW · LSE	$8.0B	94/100 Élite	57.4%low 48.6%	10 yr+	Net cash	70%	—	FY2026
7	Rightmove PLC RMV · LSE	$4.4B	94/100 Élite	60.0%low 60.0%	10 yr+	Net cash	100%	—	FY2025
8	Exponent Inc EXPO · États-Unis	$3.2B	94/100 Élite	26.7%low 22.8%	10 yr+	Net cash	60%	—	FY2025
9	Nemetschek AG O.N. NEM · XETRA	$7.2B	93/100 Élite	26.3%low 19.4%	10 yr+	0.2×	53%	—	FY2025
10	MarketAxess Holdings Inc MKTX · États-Unis	$5.7B	93/100 Élite	25.1%low 19.7%	10 yr+	Net cash	77%	—	FY2025
11	Shenzhen New Industries Biomedical 300832 · Shenzhen	$5.3B	93/100 Élite	23.5%low 17.4%	10 yr+	Net cash	75%	—	FY2025
12	Proya Cosmetics Co Ltd Class A 603605 · Shanghai	$3.3B	93/100 Élite	22.1%low 13.8%	10 yr+	Net cash	66%	—	FY2025
13	FactSet Research Systems Inc FDS · États-Unis	$9.4B	92/100 Élite	40.4%low 27.3%	10 yr+	0.6×	53%	—	FY2025
14	Genpact Limited G · États-Unis	$5.1B	92/100 Élite	20.4%low 16.8%	10 yr+	0.2×	36%	—	FY2025
15	Zhejiang Weixing New Building Materials Co Ltd 002372 · Shenzhen	$2.0B	92/100 Élite	23.9%low 15.2%	10 yr+	Net cash	43%	—	FY2025
16	Smith AO Corporation AOS · États-Unis	$8.2B	91/100 Élite	23.4%low 13.5%	10 yr+	Net cash	39%	—	FY2025
17	Jiangsu King's Luck Brewery Joint-Stock Co Ltd 603369 · Shanghai	$5.0B	91/100 Élite	19.7%low 15.7%	10 yr+	Net cash	74%	—	FY2025
18	Hubei Jumpcan Pharmaceutical Co Ltd 600566 · Shanghai	$3.4B	91/100 Élite	21.6%low 12.2%	10 yr+	Net cash	83%	—	FY2025
19	IMI PLC IMI · LSE	$8.8B	90/100 Élite	24.4%low 21.3%	10 yr+	0.5×	45%	—	FY2025
20	Chemed Corp CHE · États-Unis	$7.1B	90/100 Élite	29.2%low 18.2%	10 yr+	0.1×	33%	—	FY2025
21	Howden Joinery Group Plc HWDN · LSE	$5.5B	90/100 Élite	32.1%low 20.5%	10 yr+	0.3×	62%	—	FY2025
22	Ninety One PLC N91 · LSE	$2.7B	90/100 Élite	51.3%low 21.9%	10 yr+	Net cash	64%	—	FY2026
23	Hangzhou Robam Appliances Co Ltd 002508 · Shenzhen	$2.1B	90/100 Élite	19.8%low 10.9%	10 yr+	Net cash	53%	—	FY2025
24	Yealink Network Technology Corp Ltd 300628 · Shenzhen	$6.9B	89/100 Élite	28.7%low 20.6%	10 yr+	Net cash	67%	—	FY2025
25	MSC Industrial Direct Company Inc MSM · États-Unis	$6.9B	89/100 Élite	20.2%low 14.4%	10 yr+	0.3×	42%	—	FY2025
26	Gentex Corporation GNTX · États-Unis	$5.0B	89/100 Élite	18.6%low 15.4%	10 yr+	Net cash	36%	—	FY2025
27	Grand Canyon Education Inc LOPE · États-Unis	$3.8B	89/100 Élite	23.3%low 16.3%	10 yr+	Net cash	52%	—	FY2025
28	Anhui Gujing Distillery Co Ltd 000596 · Shenzhen	$7.0B	88/100 Élite	18.6%low 13.9%	10 yr+	Net cash	77%	—	FY2025
29	Computacenter PLC CCC · LSE	$6.1B	88/100 Élite	20.0%low 14.9%	10 yr+	Net cash	14%	—	FY2025
30	Qualys Inc QLYS · États-Unis	$5.1B	88/100 Élite	24.2%low 7.4%	10 yr+	Net cash	79%	—	FY2025
31	Rotork PLC ROR · LSE	$5.0B	88/100 Élite	16.4%low 12.2%	10 yr+	Net cash	46%	—	FY2025
32	Cohen & Steers Inc CNS · États-Unis	$4.2B	88/100 Élite	40.2%low 27.3%	10 yr+	Net cash	50%	—	FY2025
33	Robert Half International Inc RHI · États-Unis	$3.8B	88/100 Élite	30.4%low 10.4%	10 yr+	Net cash	41%	—	FY2025
34	Toro Co TTC · États-Unis	$8.7B	87/100 Élite	32.6%low 21.8%	10 yr+	0.5×	35%	—	FY2025
35	Brady Corporation BRC · États-Unis	$4.5B	87/100 Élite	14.9%low 12.1%	10 yr+	Net cash	50%	—	FY2025
36	Anhui Yingjia Distillery Co Ltd 603198 · Shanghai	$4.4B	87/100 Élite	21.0%low 16.2%	10 yr+	Net cash	66%	—	FY2025
37	HLA GROUP CORP LTD 600398 · Shanghai	$4.2B	87/100 Élite	19.8%low 11.8%	10 yr+	Net cash	39%	—	FY2025
38	Plus500 Ltd PLUS · LSE	$3.3B	87/100 Élite	52.0%low 38.8%	10 yr+	Net cash	100%	—	FY2025
39	Indutrade AB INDT · ST	$9.3B	86/100 Élite	19.6%low 15.0%	10 yr+	0.4×	34%	—	FY2025
40	Hebei Yangyuan ZhiHui Beverage Co Ltd 603156 · Shanghai	$6.8B	86/100 Élite	21.0%low 12.8%	10 yr+	Net cash	48%	—	FY2025
41	Zhejiang Supor Co Ltd 002032 · Shenzhen	$4.8B	86/100 Élite	28.8%low 23.7%	10 yr+	Net cash	26%	—	FY2025
42	Xiamen Faratronic Co Ltd 600563 · Shanghai	$4.3B	86/100 Élite	20.2%low 17.3%	10 yr+	Net cash	39%	—	FY2025
43	RS GROUP PLC RS1 · LSE	$4.3B	86/100 Élite	19.3%low 11.3%	10 yr+	0.2×	43%	—	FY2026
44	Livzon Pharmaceutical Group Inc 000513 · Shenzhen	$3.9B	86/100 Élite	16.0%low 10.2%	10 yr+	Net cash	63%	—	FY2025
45	YETI Holdings Inc YETI · États-Unis	$3.7B	86/100 Élite	35.8%low 17.0%	10 yr+	0.1×	53%	—	FY2025
46	Shanghai M&G Stationery Inc 603899 · Shanghai	$3.0B	86/100 Élite	20.8%low 14.1%	10 yr+	Net cash	23%	—	FY2025
47	Buckle Inc BKE · États-Unis	$2.3B	86/100 Élite	39.8%low 22.8%	10 yr+	0.3×	46%	—	FY2026
48	IG Group Holdings PLC IGG · LSE	$6.1B	85/100 Élite	22.8%low 16.3%	10 yr+	Net cash	90%	—	FY2025
49	Vontier Corp VNT · États-Unis	$4.5B	85/100 Élite	40.2%low 21.4%	10 yr+	1.3×	45%	—	FY2025
50	Acuity Brands Inc AYI · États-Unis	$9.8B	84/100 Élite	17.1%low 11.7%	10 yr+	0.2×	43%	—	FY2025
51	Allison Transmission Holdings Inc ALSN · États-Unis	$9.6B	84/100 Élite	49.2%low 19.9%	10 yr+	0.8×	49%	—	FY2025
52	Elisa Oyj ELISA · HE	$6.1B	84/100 Élite	28.4%low 26.4%	10 yr+	1.2×	62%	—	FY2025
53	Fuchs Petrolub SE Preference Shares FPE3 · XETRA	$5.7B	84/100 Élite	16.6%low 13.9%	10 yr+	Net cash	34%	—	FY2025
54	G-bits Network Technology Xiamen Co Ltd 603444 · Shanghai	$3.9B	84/100 Élite	28.1%low 19.3%	10 yr+	Net cash	90%	—	FY2025
55	Jiangzhong Pharmaceutical Co Ltd 600750 · Shanghai	$2.3B	84/100 Élite	15.8%low 12.2%	10 yr+	Net cash	66%	—	FY2025
56	Jafron Biomedical Co Ltd 300529 · Shenzhen	$2.1B	84/100 Élite	23.3%low 13.9%	10 yr+	Net cash	83%	—	FY2025
57	Houlihan Lokey Inc HLI · États-Unis	$8.8B	83/100 Élite	19.2%low 14.8%	10 yr+	Net cash	43%	—	FY2026
58	Huadong Medicine Co Ltd 000963 · Shenzhen	$7.1B	83/100 Élite	17.6%low 13.5%	10 yr+	Net cash	30%	—	FY2025
59	Lao Feng Xiang Co Ltd A 600612 · Shanghai	$2.6B	83/100 Élite	18.4%low 11.6%	10 yr+	Net cash	8%	—	FY2025
60	Morgan Sindall Group PLC MGNS · LSE	$2.6B	83/100 Élite	17.5%low 10.8%	10 yr+	Net cash	11%	—	FY2025
61	Shandong Himile Mechanical Science & Technology Co Ltd 002595 · Shenzhen	$8.5B	82/100 Élite	18.1%low 16.2%	10 yr+	Net cash	33%	—	FY2025
62	NewMarket Corporation NEU · États-Unis	$7.8B	82/100 Élite	35.6%low 23.5%	10 yr+	0.5×	28%	—	FY2025
63	Landstar System Inc LSTR · États-Unis	$5.9B	82/100 Élite	30.3%low 14.5%	10 yr+	Net cash	20%	—	FY2025
64	Trex Company Inc TREX · États-Unis	$4.5B	82/100 Élite	33.1%low 18.4%	10 yr+	0.2×	40%	—	FY2025
65	Chongqing Brewery Co Ltd 600132 · Shanghai	$3.1B	82/100 Élite	49.8%low 14.7%	10 yr+	Net cash	46%	—	FY2025
66	Dashenlin Pharm Grp Co Ltd 603233 · Shanghai	$3.0B	82/100 Élite	18.2%low 13.3%	10 yr+	0.0×	38%	—	FY2025
67	CSG Systems International Inc CSGS · États-Unis	$2.3B	82/100 Élite	20.0%low 12.4%	10 yr+	1.4×	48%	—	FY2025
68	Demant A/S DEMANT · CO	$9.2B	81/100 Élite	21.9%low 13.6%	10 yr+	2.3×	74%	—	FY2025
69	Andritz AG ANDR · VI	$8.6B	81/100 Élite	19.2%low 10.6%	10 yr+	—	49%	—	FY2025
70	Simpson Manufacturing Company Inc SSD · États-Unis	$7.8B	81/100 Élite	17.2%low 10.4%	10 yr+	0.1×	46%	—	FY2025
71	Spirax Group plc SPX · LSE	$6.5B	81/100 Élite	20.6%low 13.4%	10 yr+	0.5×	50%	—	FY2025
72	Shanghai Friendess Electronics Tech 688188 · Shanghai	$5.9B	81/100 Élite	27.3%low 11.2%	10 yr+	Net cash	82%	—	FY2025
73	Huali Industrial Group Company Limited 300979 · Shenzhen	$5.8B	81/100 Élite	30.9%low 19.7%	9 yr	Net cash	23%	—	FY2025
74	Temenos Group AG TEMN · SW	$5.7B	81/100 Élite	36.0%low 19.7%	10 yr+	1.2×	70%	—	FY2025
75	Hisense Kelon Electrical Holdings Co Ltd 000921 · Shenzhen	$5.3B	81/100 Élite	19.1%low 9.4%	10 yr+	Net cash	21%	—	FY2025
76	Lancaster Colony Corporation LANC · États-Unis	$4.8B	81/100 Élite	17.8%low 10.6%	10 yr+	Net cash	24%	—	FY2024
77	Royal Unibrew A/S RBREW · CO	$3.6B	81/100 Élite	29.8%low 19.1%	10 yr+	0.9×	48%	—	FY2025
78	Shanghai Huace Navigation Technology Ltd 300627 · Shenzhen	$3.2B	81/100 Élite	17.0%low 12.2%	10 yr+	Net cash	60%	—	FY2025
79	The Marzetti Company MZTI · États-Unis	$2.9B	81/100 Élite	17.7%low 10.6%	10 yr+	Net cash	24%	—	FY2025
80	AIMA Technology Group Co Ltd 603529 · Shanghai	$2.7B	81/100 Élite	25.4%low 13.3%	10 yr+	Net cash	15%	—	FY2025
81	Dino Polska SA DNP · WAR	$8.6B	80/100 Élite	24.2%low 18.0%	10 yr+	Net cash	24%	—	FY2025
82	Edenred SA EDEN · Paris	$7.3B	80/100 Élite	60.0%^‡low 60.0%	10 yr+	—	48%	—	FY2025
83	China Resources Sanjiu Medical & Pharmaceutical Co Ltd 000999 · Shenzhen	$6.0B	80/100 Élite	14.4%low 11.6%	10 yr+	Net cash	60%	—	FY2025
84	Auto Trader Group plc AUTO · LSE	$5.2B	80/100 Élite	51.1%low 27.9%	10 yr+	0.5×	91%	—	FY2026
85	Frontdoor Inc FTDR · États-Unis	$5.1B	80/100 Élite	49.5%low 22.1%	10 yr+	2.7×	47%	—	FY2025
86	Badger Meter Inc BMI · États-Unis	$3.9B	80/100 Élite	15.1%low 9.2%	10 yr+	Net cash	39%	—	FY2025
87	Jiangsu Nhwa Pharmaceutical Co Ltd 002262 · Shenzhen	$3.1B	80/100 Élite	16.2%low 13.1%	10 yr+	Net cash	66%	—	FY2025
88	Artisan Partners Asset Management Inc APAM · États-Unis	$2.8B	80/100 Élite	58.6%low 45.9%	10 yr+	0.4×	49%	—	FY2025

Data and methodology: the six dimensions quantify Berkshire's published acquisition criteria and Buffett's shareholder letters (1981/1987/1991/2007 among others). Qualitative tests in the originals (e.g. "simple, understandable business", "management in place") are out of scope, and price ("available at a fair price") is covered by each report's valuation range instead. Financials come from company annual reports (via EODHD); ratios are computed in reporting currency, the USD gate via static FX. "‡" marks companies whose equity is persistently negative or tiny (ROE falls back to ROCE); "†" marks missing gross profit (operating margin used). Investment trusts and closed-end funds are excluded on two tests — name and financial shape (operating margins beyond what an operating company can achieve); REITs and operating asset managers are unaffected. This is a quantitative first pass, not investment advice. When citing this data, please credit Zen Horizon (zh.app). See our methodology for the scoring process.